Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionTudor Investment Corp Et Al
ManagerPaul Tudor Jones
Latest Disclosed Ownership102,867 shares
Latest Disclosed Value $ 234,537
Tudor Investment Corp Et Al ownership in 9EH / Evolent Health, Inc.

On May 15, 2026 - Tudor Investment Corp Et Al filed a 13F-HR form disclosing ownership of 102,867 shares of Evolent Health, Inc. (DE:9EH) valued at $194,419 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 702,121 shares of Evolent Health, Inc.. This represents a change in shares of -85.35% during the quarter. The current value of the position is $347,690 USD.

Tudor Investment Corp Et Al has a history of taking positions in derivatives of the underlying security (9EH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9EH / Evolent Health, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Evolent Health Inc - US Equity 30050B101 102,867 -599,254 -85.35 235 -91.67 0.0004
2026-02-17 2025-12-31 13F Evolent Health Inc - US Equity 30050B101 702,121 12,859 1.87 2,808 -51.84 0.0052
2025-12-09 2025-09-30 13F/A-1 Evolent Health Inc - US Equity 30050B101 689,262 438,095 174.42 5,831 106.19 0.0101
2025-11-14 2025-09-30 13F Evolent Health InC - US Equity 30050B101 689,262 438,095 5,831 0.0098
2025-08-14 2025-06-30 13F Evolent Health Inc - US Equity 30050B101 251,167 -400,819 -61.48 2,828 -54.20 0.0062
2025-05-15 2025-03-31 13F Evolent Health Inc - US Equity 30050B101 651,986 325,726 99.84 6,174 68.23 0.0205
2025-02-14 2024-12-31 13F Evolent Health Inc - US Equity 30050B101 326,260 160,769 97.15 3,670 -21.58 0.0140
2024-11-14 2024-09-30 13F Evolent Health Inc - US Equity 30050B101 165,491 -249,713 -60.14 4,680 -41.04 0.0170
2024-08-14 2024-06-30 13F Evolent Health Inc - US Equity 30050B101 415,204 -6,215 -1.47 7,939 -42.55 0.0407
2024-05-15 2024-03-31 13F Evolent Health Inc - US Equity 30050B101 421,419 312,106 285.52 13,818 282.77 0.0879
2024-02-14 2023-12-31 13F Evolent Health Inc - US Equity 30050B101 109,313 109,313 3,611 0.0291
2023-08-14 2023-06-30 13F Evolent Health Inc - US Equity 30050B101 0 -109,715 -100.00 0 -100.00
2023-05-15 2023-03-31 13F Evolent Health Inc - US Equity 30050B101 109,715 109,715 4 0.0551
2023-02-14 2022-12-31 13F Evolent Health Inc - US Equity 30050B101 0 -41,235 -100.00 0 -100.00
2022-11-14 2022-09-30 13F Evolent Health Inc - US Equity 30050B101 41,235 41,235 1,482 0.0320
2022-02-14 2021-12-31 13F Evolent Health Inc - A Equity 30050B101 0 -125,000 -100.00 0 -100.00
2021-11-17 2021-09-30 13F/A-1 Evolent Health Inc - A Equity 30050B101 125,000 125,000 3,875 0.0629
2021-11-15 2021-09-30 13F Evolent Health Inc - A Equity 30050B101 125,000 125,000 3,875 0.0103
2021-08-16 2021-06-30 13F Evolent Health Inc - A Equity 30050B101 0 -16,869 -100.00 0 -100.00
2021-05-17 2021-03-31 13F Evolent Health Inc - A Equity 30050B101 16,869 -45,817 -73.09 341 -66.07 0.0068
2021-02-16 2020-12-31 13F Evolent Health Inc - A COMMON STOCK 30050B101 62,686 62,686 1,005 0.0284
2016-05-16 2016-03-31 13F Evolent Health Inc - A COMMON STOCK 30050B101 0 -15,200 -100.00 0 -100.00
2016-02-16 2015-12-31 13F Evolent Health Inc - A COMMON STOCK 30050B101 15,200 0 0.00 184 -24.28 0.0052
2015-11-16 2015-09-30 13F Evolent Health Inc - A COMMON STOCK 30050B101 15,200 -32,019 -67.81 243 -73.62 0.0082
2015-08-14 2015-06-30 13F Evolent Health Inc - A COMMON STOCK 30050B101 47,219 47,219 921 0.0269
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F Evolent Health Inc - US Equity Option Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F Evolent Health Inc - US Equity Option Call 11,600 130 n/a n/a n/a
2023-02-14 2022-12-31 13F Evolent Health Inc - US Equity Option Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F Evolent Health Inc - US Equity Option Call 5,700 206 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.